SS

Satpal Singh

Active Director Director DIN 08584872
DIN 08584872 First appointment Oct 2019 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2019
Shareholding value •••• Premium profile

About Satpal Singh

Data last updated:

Satpal Singh is a Director at Vet Blessing Pharmaceutical Private Limited (since 2019). The company operates in Pharma. Vet Blessing Pharmaceutical Private Limited reported revenue of ₹1.9 Lakh (FY 2020).

DIN 08584872
Primary Designation Director
Industry Pharma
First Appointment 11 Oct 2019
Oldest Company Age 7 yrs
Largest company Vet Blessing Pharmaceutical Private Limited · ₹1.9 Lakh (FY 2020)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director11 Oct 20192019₹1.9 Lakh (FY 2020)Active

Board colleagues of Satpal Singh

Directorship timeline

Open interactive timeline →
Vet Blessing Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Satpal Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Satpal Singh

Satpal Singh currently holds 1 directorship: Vet Blessing Pharmaceutical Private Limited (Director, since 11 Oct 2019, revenue ₹1.9 Lakh (FY 2020)).

Satpal Singh was first appointed on 11 Oct 2019 as Director at Vet Blessing Pharmaceutical Private Limited.

The current boards of Satpal Singh's companies include Amar Deep (Vet Blessing Pharmaceutical Private Limited), Sandeep Kumar (Vet Blessing Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available